Volume-led growth is back
Q2 turnover ₹18,071cr; underlying sales +15%, volume +7%.
Watch: WATCH margin conversion and clean PAT.
Home / Research / Hindustan Unilever Limited
Volume-led growth is back
Q2 turnover ₹18,071cr; underlying sales +15%, volume +7%.
Watch: WATCH margin conversion and clean PAT.
Reported EBITDA +8% YoY versus 15% underlying sales growth.
Watch: Review cost/mix and margin.
Home Care USG 22% led by double-digit UVG, broad across fabric and household.
Watch: Watch volume resilience and pricing.
Beauty & Wellbeing USG 16%, supported by premium innovation and double-digit volume.
Watch: Review promotional investment economics.
SAGE PRO | September quarter 2026 / Q2 FY2027 | 17 November 2026 | NSE: HINDUNILVR Stance: WATCH with constructive operating momentum. This seven-chapter research report uses Sage PRO's existing accepted September-quarter issuer presentation and earnings call. It is not a price-target forecast.
Key takeaways
What is risky. EBITDA grew 8%, slower than underlying sales, while the EBITDA margin was 22.6%. Commodity inflation, premiumization costs and channel investments mean the strong top line cannot automatically be converted into a matching profit rate. Personal Care and Foods grew only 9% on the issuer's underlying sales definition.
What valuation demands. The franchise is valued on durable volume-led profit growth, brand strength and cash generation rather than short-term promotional sales. A numeric target would require a verified dated price, sustainable margin assumptions and comparable financial data, so it is not invented here.
| Company-reported measure | Q2 FY27 | Basis |
|---|---|---|
| Turnover | ₹18,071 crore | September-quarter company turnover |
| Underlying sales growth | 15% | Excludes acquisitions/disposals impact |
| Underlying volume growth | 7% | Company's volume growth definition includes mix |
| EBITDA | ₹4,089 crore | +8% YoY, company disclosure |
| EBITDA margin | 22.6% | Within guided range |
| PAT before exceptional items | ₹2,795 crore | +9% YoY |
| Reported PAT | ₹2,796 crore | Broadly flat YoY; prior year included ₹273 crore one-off tax-related gains |
| H1 FY27 turnover | ₹35,255 crore | Six months to September, not a single quarter |
| Interim dividend | ₹19/share | Board declaration for FY27 |
Why it matters. Volume-led growth is returning, but margin and clean profit growth determine how much of that revenue expansion accrues to shareholders.
---
Key takeaways
The September quarter provided a stronger operating foundation than many preceding quarters: 7% UVG accompanied 15% USG, rather than a purely price-driven headline. Management highlighted the highest underlying sales growth in 14 quarters and broad-based gains across multiple categories.
The strategic question is whether higher volume is structural enough to support selective price increases and innovation investment. A company can show excellent underlying sales growth yet earn a smaller incremental profit margin if advertising, premium launches, commodity inflation or channel competition absorb the proceeds.
Bull thesis: a broader premium portfolio and more efficient distribution support persistent volumes, good brand margins and improving returns on reinvestment.
Counter-thesis: competitive pricing, retailer/channel economics and rising input costs make volume gains expensive; high-growth emerging categories consume resources before generating comparable contribution profit.
Investment test: the next two quarters' volume growth, EBITDA conversion and growth in PAT before exceptional items, not just net sales.
---
Key takeaways
EBITDA increased 8% year-on-year, slower than the 15% USG increase. The difference does not by itself indicate deterioration—USG is a management-adjusted growth measure and reported sales are not an identical denominator—but it demonstrates that margin and cost dynamics deserve explicit examination.
Clean profit comparison: PAT before exceptional items rose 9% to ₹2,795 crore. Reported PAT of ₹2,796 crore was broadly flat because the prior-year base benefited from ₹273 crore of exceptional, tax-related gains. A superficial comparison of reported PAT would understate the growth of the ordinary business; ignoring the official exceptional-item bridge would overstate comparability.
For the first half of FY27, turnover totaled ₹35,255 crore, USG was 12%, UVG was 6% and PAT before exceptional items grew 9%. These are six-month observations and should not be entered as a single quarterly figure.
The board declared an interim dividend of ₹19/share. A declaration indicates a return-of-cash decision, but it is not evidence of a specific free-cash-flow figure in this quarter. Dividend yield requires a valid price observation and is not computed here.
Why it matters: Investors should reward sustainable growth in actual profit and cash generation more than a one-quarter acceleration in an adjusted top-line metric.
---
| Segment | Q2 FY27 USG | Read-through |
|---|---|---|
| Home Care | 22% | Double-digit volume growth, liquids and broad fabric/household strength |
| Beauty & Wellbeing | 16% | Double-digit volume-led premium skin and hair expansion |
| Personal Care | 9% | Skin-cleansing strength, oral-care growth more moderate |
| Foods | 9% | Growth in nutrition and packaged foods, with low-single-digit segment UVG |
Key takeaways
Beauty & Wellbeing delivered 16% USG alongside premium skin and hair-care momentum. Innovation included new launches and the expansion of Simple and other premium offerings. Product novelty and premium shelf space may sustain growth, but advertising intensity and repeat purchase determine profit.
Personal Care showed 9% USG. Skin cleansing performed more strongly than the broader segment, while oral care was more moderate. This matters because legacy mass-market categories and premium innovation may need different volume and price assumptions.
Foods recorded 9% USG, with low-single-digit volume growth. Nutrition, packaged foods and coffee were areas of focus. Horlicks protein-powder expansion illustrates new-product adjacency; early traction is not a proven profit pool.
Investor implication: The portfolio is broad, but growth quality varies. Track volume and margin by segment, using consistent issuer definitions and avoiding unsupported segment-level profit figures.
---
Key takeaways
General trade. Management reported adding 30,000 outlets to distribution coverage during the quarter while increasing assortment across outlets. Added reach is valuable if it creates sustained sell-through; shipping more stock into the channel does not guarantee matching consumer demand.
Modern trade. The company described stepping up category-development asset deployment. This can support premium visibility, but newer investments require evidence of category contribution and retailer economics.
E-commerce and quick commerce. Technology-led service improvements and an omnichannel approach support emerging consumer behavior. The commercial opportunity includes availability, personalized assortment and brand discovery. The risk is higher fulfillment, promotional or channel margin costs.
Innovation. Examples include extensions in beauty, skin care, nutrition and household formats. The key is whether the innovations create incremental profitable demand, rather than cannibalizing an established product at higher marketing expense.
Why it matters: Distribution expansion and premiumization are believable sources of growth. They are not themselves a cash-flow forecast; evaluate same-store productivity, household penetration and advertising/retailer trade-offs.
---
Key takeaways
The crucial investor trade-off is between immediate margin expansion and defending brand quality or reaching emerging channels. Accepting temporary promotional costs may be economically rational if retention and lifetime profitability improve; repeated spending without measurable consumer gains would undermine that case.
Reported capital distribution. The ₹19/share interim dividend is a clear management action. It should not be used to impute undisclosed net debt, free cash flow or future buyback capacity. The research uses management's accepted quarterly disclosures; precise cash-flow and balance-sheet claims are left to the original detailed statements.
Supply chain and procurement. Management described continuity in key materials despite volatile geopolitical and input-price conditions. Resilience is strategically important, but reported profitability is the correct test of whether supply-chain benefits offset commodity inflation.
Q&A interpretation. The company spent substantial call time addressing consumer demand, innovation, margin and channels. Rather than assigning numerical scores to management's tone, the measurable response is whether underlying volumes remain healthy while EBITDA and clean PAT improve on comparable definitions.
Next-quarter checks: volume contribution across Home Care and Beauty, the gross margin and advertising bridge, Foods/Personal Care momentum, distribution productivity and the actual cash cost of new-channel expansion.
---
| Risk | How it affects profit | Observable monitor |
|---|---|---|
| Commodity input inflation | Can compress gross margin or force price increases | Material-cost trend, price/mix versus UVG |
| Category competition | Forces advertising and price promotions | Volume growth and segment price actions |
| Premium innovation execution | Product launches may not retain customers | Repeat purchase, segment sales and margins |
| Channel investment | New routes to market can cost more to serve | Distribution productivity, trade spend |
| Demand divergence | Consumption gains may favor only a few categories | Home Care vs Foods/Personal Care UVG |
| Exceptional-item comparability | Reported PAT may mislead | PAT before exceptional items and exact disclosed bridge |
Key takeaways
Base operating case: volume growth remains healthy but commodity and brand investment costs limit margin expansion. Reported EBITDA grows in mid-to-high single digits while management deploys resources into newer growth pools.
Bear operating case: price-sensitive consumers trade down, competitors retaliate, input costs rise and premium growth loses momentum. The company incurs ongoing channel investments without enough incremental gross profit.
These are operating descriptions, not unsupported numerical price targets. A scenario valuation would need current shares/price, comparable cash flow, a margin bridge and defensible forecasts.
Thesis breakers: sustained volume deceleration, repeated clean-PAT underperformance relative to sales, large marketing cost increases with weak retention and adverse commodity-price swings without pricing power.
---
Five observable questions for Q3 FY27:
Key takeaways
[1] HUL September Quarter 2026 results / investor presentation, dated 28 October 2026, document 79702. It provides the company turnover, USG/UVG, financial and segment disclosures. Original issuer link:
[2] HUL September Quarter 2026 earnings call, held 28 October 2026, document 72865. It supplies management's strategic and operating explanations. Original issuer link:
Both documents were accepted previously in Sage PRO and reused. No new extraction, re-review or re-scoring took place. The existing AI research score remains a separate product.
Simple note: This report uses company disclosures. Unsupported financial forecasts and valuations have been left out.
Glossary. USG: underlying sales growth excluding acquisition/disposal changes. UVG: underlying volume growth, including mix effects under HUL's definition. PAT before exceptional items: clean management-reported after-tax measure excluding specified exceptional effects. EBITDA: earnings before interest, taxes, depreciation and amortization, as reported by the issuer.
Bottom line: The strongest aspect of HUL's September quarter is its renewed, broad-based volume-led demand. The next investment test is whether that demand supports sustainable clean profit and cash returns after brand and channel investment.
Original references are in the published manuscript below.
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.